Hester Biosciences informs about credit rating

09 Jan 2020 Evaluate

Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulations), Hester Biosciences has informed that CARE Ratings, with its letter dated 8 January 2020 (received by Company on 9 January 2020), has revised the ratings to the Company. The revision in credit ratings were issued due to additional term loan facility sanctioned by the Bank.

The above information is a part of company’s filings submitted to BSE.

Hester Biosciences Share Price

1427.50 22.55 (1.61%)
19-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1744.35
Dr. Reddys Lab 1274.05
Cipla 1238.65
Zydus Lifesciences 876.35
Lupin 2253.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×